Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Crown Bioscience
Biotech
Gilead's accounting chief hits the exit—Chutes & Ladders
Gilead’s accounting chief hits the exit. Geron chief says goodbye. ITM preps for launch with leadership shake-up.
Darren Incorvaia
,
Zoey Becker
Mar 14, 2025 8:30am
Crown Bioscience, HanX pact shows promise of lymphoma drug
Aug 24, 2023 5:00am
Crown Bioscience, JSR team to acquire IndivuServ unit
Jan 31, 2023 3:10pm
Crown Bioscience inks deal with ERS for gene editing technology
Dec 12, 2022 3:05pm
Crown Bioscience rejigs executive team, plans global expansion
Aug 2, 2022 8:57am
Amgen vet to be CMO at Affini-T—Chutes & Ladders
Jul 29, 2022 9:30am
